Home/Recalls/FDA-D-0552-2026
FDA DrugsClass III

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Via...

Published: June 10, 2026Recall ID: D-0552-2026Category: drugsCountry: US

Reason for Recall / Hazard

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Product Description & Identification

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Affected Products

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Additional Source Details

FieldValue
CityEast Windsor
StateNJ
Openfda › Route › 1EPIDURAL
Openfda › Route › 2INFILTRATION
Openfda › Route › 3INTRA-ARTICULAR
Openfda › Route › 4INTRAMUSCULAR
Openfda › Route › 5TOPICAL
Openfda › Rxcui › 1797730
Openfda › Rxcui › 21737757
Openfda › Rxcui › 31792144
Openfda › Spl id47db1f9e-f201-2918-e063-6394a90a82e9
Openfda › Brand nameLIDOLOG KIT
Openfda › Spl set id069e145d-7992-4f56-9fcb-20782ecc2d53
Openfda › Package ndc › 176420-760-01
Openfda › Package ndc › 255150-164-02
Openfda › Package ndc › 370121-1049-5
Openfda › Package ndc › 467777-419-02
Openfda › Product ndc76420-760
Openfda › Generic nameLIDOCAINE, KENALOG, POVIDONE IODINE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Manufacturer nameAsclemed USA, Inc.
Openfda › Is original packagertrue
Event id99024
Address 1279 Princeton Hightstown Rd
Code infoLot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Postal code08520-1401
Report date20260610
Product typeDrugs
Product quantity168,300 vials
Reason for recallLabeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260518
Initial firm notificationLetter
Center classification date20260529

Overview

  • Recalling FirmEugia US LLC
  • StatusOngoing
  • Risk LevelClass III
  • DistributionUS Nationwide.
Official Agency Alert